Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | CASP1 | P29466 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17404015 | 0.98 | ALDH1A1 (0.35) | ALDH1A1HPGDTSHRMAPK1CASP1 | |
| SCHEMBL17404047 | 0.96 | ALDH1A1 (0.38) | ALDH1A1HPGDTSHRMAPK1CASP1 | |
| SCHEMBL17404070 | 0.95 | ALDH1A1 (0.31) | ALDH1A1HPGDTSHRMAPK1CASP1 | |
| SCHEMBL17404077 | 0.95 | ALDH1A1 (0.34) | ALDH1A1HPGDTSHRMAPK1CASP1 | |
| SCHEMBL17404080 | 0.95 | ALDH1A1 (0.31) | ALDH1A1HPGDTSHRMAPK1CASP1 | |
| SCHEMBL17404098 | 0.93 | ALDH1A1 (0.31) | ALDH1A1HPGDTSHRMAPK1CASP1 | |
| SCHEMBL17404083 | 0.93 | PDK2 (0.32) | ALDH1A1HPGDTSHRMAPK1CASP1 | |
| SCHEMBL17404100 | 0.92 | ALDH1A1 (0.35) | ALDH1A1HPGDTSHRMAPK1CASP1 | |
| SCHEMBL17404066 | 0.92 | GPR84 (0.32) | PDK2 | |
| SCHEMBL17404104 | 0.92 | ALDH1A1 (0.35) | ALDH1A1HPGDTSHRMAPK1CASP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9793500-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-10-17 | — | — | US | disclosed |
| US-9793500-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-10-17 | — | — | US | disclosed |
| US-20160005984-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-01-07 | — | — | US | disclosed |
| US-20160005984-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-01-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160005984-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CCNT1, CCNE2, CCNE1 | ALDH1A1 896/4885HPGD 3913/4885TSHR 2045/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.